Myelination in the central nervous system takes place predominantly during the postnatal development of humans and rodents by myelinating oligodendrocytes (OLs), which are differentiated from oligodendrocyte progenitor cells (OPCs). We recently reported that Sox2 is essential for developmental myelination in the murine brain and spinal cord. It is still controversial regarding the role of Sox2 in oligodendroglial lineage progression in the postnatal murine spinal cord. Analyses of a series of cell-and stage-specific Sox2 mutants reveal that Sox2 plays a biphasic role in regulating oligodendroglial lineage progression in the postnatal murine spinal cord. Sox2 controls the number of OPCs for subsequent differentiation through regulating their proliferation. In addition, Sox2 regulates the timing of OL differentiation and modulates the rate of oligodendrogenesis. Our experimental data prove that Sox2 is an intrinsic positive timer of oligodendroglial lineage progression and suggest that interventions affecting oligodendroglial Sox2 expression may be therapeutic for overcoming OPC differentiation arrest in dysmyelinating and demyelinating disorders.
Introduction
Oligodendrocytes are CNS myelin-forming cells. Oligodendroglial lineage progression encompasses multiple sequential steps including OPC generation, migration, proliferation, differentiation into premyelinating OLs (i.e., OL differentiation), and myelination by myelinating OLs [1] . Perturbation of any steps could result in myelination impairment.
In the CNS, the SRY (sex-determining region Y)-box 2, Sox2 is highly expressed in NSCs [2, 3] and maintains the properties of neural stem cells (NSCs) and progenitor cells [4, 5] . In line with its role in NSC/progenitor cells, recent data have shown that overexpression of Sox2 converts differentiated astrocytes and OPCs back into neural progenitor cells in vivo under certain circumstances [6] [7] [8] . However, there are Bconflicting^observations in the current literatures regarding the role of Sox2 in the spinal cord oligodendrocyte development. Hoffmann and colleagues reported that Sox2 is dispensable for OPC proliferation and migration, but essential for OL differentiation and myelination in the perinatal spinal cord [9] . A recent study by Zhao et al. reported that Sox2 seems dispensable for OL differentiation and myelination in the postnatal spinal cord [10] . However, this study employed animal models of non-cell-specific Sox2 deletion driven by the actin promoter. More recently, we used animal models of cellspecific Sox2 deletion driven by the Sox10 promoter (Sox10-Cre:Sox2 fl/fl ) and found that Sox2 is required for developmental myelination in the murine spinal cord and brain [11] . These discrepant observations prompted us to revisit the role of Sox2 in oligodendroglial lineage progression in the postnatal spinal cord by leveraging our cell-and stagespecific animal models of Sox2 deletion.
To this end, we used Sox10-Cre:Sox2 fl/fl animal model to constitutively delete Sox2 in OPCs and tamoxifen-inducible Pdgfrα-CreER T2 :Sox2 fl/fl to delete Sox2 in OPCs at the neonatal ages. In addition, we used Cnp-Cre:Sox2 fl/fl animal model to constitutively delete Sox2 in differentiation-committed OPCs and their progenies and tamoxifen-inducible PlpCreER T2 :Sox2 fl/fl to time-conditionally delete Sox2 in differentiation-committed OPCs and their progenies. Through analysis and comparison of oligodendrocyte lineage phenotypes among these Sox2 mutants, we concluded that Sox2 is an intrinsic bi-phasic regulator of oligodendroglial proliferation and differentiation during developmental myelination of postnatal murine spinal cord, as we recently reported in the postnatal brain [11] .
Results
Our recent data show that Sox2 is expressed in OPCs and upregulated in newly differentiated OLs during CNS developmental myelination [11] . Here, we employed the genetic approach of Cre-loxP-mediated labeling and demonstrated that Sox2 was expressed in all OPCs regardless of their CNS regional origins (Fig. 1 ). 
Sox2 Is Specifically and Efficiently

Mutants
Sox10 expression is absent from embryonic NSCs (i.e., neuroepithelial cells) and starts in OPCs immediately after OPC specification from NSCs at~embryonic 12.5 days (E12.5) in the mouse spinal cord [12] . Accordingly, Sox10-Cre-mediated Sox2 deletion was observed in all P D G F R α + O P C s ( F i g . 2 a 1 -a 2 ) b u t n o t i n t h e neuroepithelial cells at the ventricular zone (boxed areas in Fig. 2a1-a2 ). fl/fl controls (arrowheads in Fig. 2c1 vs Fig. 2c2, Fig. 2d ) at E15.5,~3 days after OPC specification. Our results suggest that Sox2 is dispensable for OPC proliferation and migration in the embryonic spinal cord, which is consistent with the previous data [9] .
OPC Proliferation and Migration in the Embryonic
Hypomyelination in the Adult Spinal Cord of Sox10-Cre:Sox2 fl/fl Mutants
Our recent data show that Sox10-Cre:Sox2 fl/fl mutants display tremors and ataxia (indicators of hypomyelination) and impaired performance on accelerating Rotarod [11] at P28, an approximate time point that oligodendrocyte differentiation and developmental myelination are close to completion in the murine spinal cord. In this study, we found that myelination impairment persisted into the adult ages, as assessed by diminished density of myelinated axons in CST of Sox10-Cre:Sox2 fl/fl mutants at P60, compared with littermate control mice (Fig. 3) . Our previous and current data suggest that Sox2 is essential for developmental myelination in the murine spinal cord. (Fig. 4e ) was significantly decreased in Sox10-Cre:Sox2 fl/fl mutants compared with that in non-Cre controls. We used Sox10 and Ki67 to identify cycling OPCs (Fig. 4g , arrowheads) and found that the number of proliferating OPCs was also significantly reduced in the mutant white matter (Fig. 4f) . We have shown that TCF7l2 [13] and APC [14] are upregulated and co-expressed in newly formed premyelinating OLs and dramatically downregulated in mature myelinating OLs. Therefore, the number of TCF7l2 + APC + cells at any given time provides a quantitative indication of the rate of OL generation from OPCs, or oligodendrogenesis. Our quantification data showed a 75% reduction of TCF7l2 + APC + newly formed premyelinating OLs in the white matter of Sox10-Cre:Sox2 fl/fl mutants compared with non-Cre controls (Fig. 4h-i) . These data indicate that Sox2 positively regulates oligodendroglial lineage progression and the rate of oligodendrogenesis in the early postnatal spinal cord.
A recent study reported that oligodendroglial lineage progression was normal by the second postnatal week (P14) in the spinal cord of Sox2 ubiquitously ablated mice (Cag-CreER™:Sox2 fl/fl ) [10] . However, our recent data demonstrated that oligodendroglial lineage progression was persistently impaired in the spinal cord of Sox10-Cre:Sox2 fl/fl mice even at later states of spinal cord development [11] . In line with our recent histological data of diminished number of OPCs and OLs, RT-qPCR quantification showed that the mRNA levels of OL lineage genes, Sox10, Pdgfrα, Plp-E3b, Cnp, CC1, and Enpp6, and fl/fl mice compared with non-Cre controls (Fig. 5a ). Western blot verified the reduced protein level of myelin genes MBP and CNP (Fig. 5b) . Therefore, our previous and current data suggest that oligodendroglial lineage progression is persistently impaired even during the later stages of spinal cord development.
Collectively, the time-course data obtained from fl/fl mutants at P19. a RT-qPCR quantification of spinal cord mRNA levels of Sox2, Sox10, Pdgfrα, Plp-E3b (exon3b-containing proteolipid protein), Cnp, Qk (also known as CC1), and premyelinating OL-specific Enpp6 at P19. Gene expression was normalized to the internal control Hsp90, and the level in non-Cre Ctrl was set to 1. N = 7 nonCre control (black circles) and 4 Sox2 cKO (red triangles), two-tailed Student's t test [t (9) = 5.397 Sox2, t (9) = 3.131 Sox10, t (9) = 2.437 Pdgfrα, t (9) = 11.71 Plp-E3b, t (9) = 5.145 Cnp, t (9) = 4.487 Qk, and t (9) = 2.734 Enpp6]. b Western blotting of myelin proteins MBP and CNP, and the loading control β-actin in the P19 spinal cord spinal cord was harvested at P8 and P26 (Fig. 6a) fl/fl mutants at both P8 and P26, compared with that of non-Cre littermate controls (41% reduction at P8 and 17% at P26) (Fig. 6e) , suggesting that Sox2 is required for maintaining OPC population during postnatal spinal cord development.
The decreased OPC population would lead to reduced number of differentiated oligodendrocytes. Accordingly, we found that OL differentiation and myelination were impaired in the spinal cord of Pdgfrα-CreER Fig. 6g) . Consistently, the mRNA levels of myelin genes Mbp, Plp-E3b, and Mog ( Fig. 6h) :Sox2 cKO mice compared with non-Cre littermate controls at both P8 and P26 (Fig. 6k, right) . Collectively, these data indicate that Sox2 promotes OPC population supply for subsequent OL differentiation.
OPC population is maintained by proliferation, apoptosis, or both. We then analyzed OPC proliferation and apoptosis. Our data showed that the percentage of Ki67 + cycling OPCs was significantly reduced at both P8 (by 42%) and P26 (by 43%) in the spinal cord of Pdgfrα-CreER T2 :Sox2 cKO mice (Fig. 7b, c, d ), which is confirmed by 2 h EdU pulse labeling (Fig. 7e) . However, we found no alterations in the density of active Caspase 3 + apoptotic cells in the spinal cord of Pdgfrα-CreER T2 :Sox2 cKO mice in comparison to non-Cre controls at P8 and P26 (Fig. 7f) . Of note, our in vivo data are different from those collected from in vitro system in which Sox2 ablation significantly increases caspase-dependent OPC apoptosis [10] .
Taken together, the data obtained from the time-conditional Pdgfrα-CreER To determine the role of Sox2 in OL differentiation without compromising OPC population, we analyzed the spinal cord of Cnp-Cre:Sox2 fl/fl mice in which Cre-recombinase mediates gene deletion primarily in post-mitotic differentiation-committed OPCs and later stages of OLs [15] [16] [17] [18] [19] [20] [21] .
At P8, immunohistochemistry confirmed that Sox2 was specifically deleted in Olig2 + oligodendroglial lineage cells in the spinal cord of Cnp-Cre:Sox2 fl/fl mutants (Fig. 8b, c) . The density of Olig2 + pan-oligodendroglial lineage cells (Fig. 8d) and Olig2 (Fig. 8f) , indicating that Sox2 is primarily ablated in post-mitotic OPCs and later stages of OLs. Consistent with the histological data, we observed significant decreases in the mRNA levels of the pan-oligodendroglial lineage marker Sox10, mature OL-enriched genes Plp-E3b (exon3b-containing Plp), Mbp, Mag, and Mog (Fig. 8g) , and premyelinating OLenriched genes Enpp6, Tcf7l2, Bcas1, Ugt8a, and Bmp4 (Fig. 8h) , indicating that OL differentiation is inhibited in the P8 spinal cord of Cnp-Cre:Sox2 fl/fl mice. Our recent data report that oligodendrocyte number and myelin gene expression are normal in the P14 spinal cord of Cnp-Cre:Sox2 fl/fl mice [11] . In the current study, we showed that OPC density was unchanged in the P14 spinal cord of Cnp-Cre:Sox2 fl/fl mice compared with that in the non-Cre controls (Fig. 8i) . Interestingly, the number of APC + /TCF7l2 + newly formed premyelinating OLs (Fig. 8k, arrowheads) was significantly decreased in the spinal cord WM and GM of Cnp-Cre:Sox2 fl/fl mice at P14 (Fig. 8j) , indicating that the rate of oligodendrogenesis is impaired. Consistently, myelination was inhibited in the spinal cord at P8 (Fig. 9a, b) and seemed normal in the adult of Cnp-Cre:Sox2 fl/fl mice (Fig. 9c, d ). Accelerating Rotarod test showed that Cnp-Cre:Sox2 fl/fl mutants still exhibited impaired motor coordination at the adult age compared with non-Cre control mice (Fig. 9e) , which is presumably due to the myelin abnormalities in the peripheral nervous system. 
Mutants
To corroborate the conclusion that Sox2 enhances the rate of oligodendrocyte generation, we created the tamoxifeninducible, time-conditional Plp-CreER T2 :Sox2 fl/fl transg e n i c m i c e . Ta m o x i f e n w a s i n j e c t e d t o P l pCreER T2 :Sox2 fl/fl mice and non-Cre littermate controls at P10, P11, and P13, and spinal tissues were assessed at P14 (Fig. 10a ). Sox2 and Olig2 immunostaining confirmed that Sox2 was deleted in most Olig2 + oligodendroglial lineage cells (Fig. 10b) . Our quantification data showed that Olig2 + /PDGFRα + OPCs were similar (Fig. 10c ) whereas Olig2 + /CC1 + OLs were reduced in the spinal cord Tukey's posthoc test was used for pairwise comparisons, **P < 0.001, ***P < 0.0001, ns, not significant. g-h RT-qPCR quantification of mRNA expression of indicated genes in P8 spinal cord. mRNA level was normalized to the internal control Hsp90, and the level in Sox2 Ctrl was set to 1. Two-tailed Student's t test [t (7) = 2.957 Sox2, t (7) = 8.307 Sox10, t (7) = 3.660 Plp-E3b, t (7) = 3.386 Mbp, t (7) = 5.252 Mag, t (7) = 4.782 Mog, t (7) = 3.331 Enpp6, t (7) = 4.129 Tcf7l2, t (7) = 4.688 Bcas1, t (7) = 3.950 Ugt8a, t (7) = 2.383 Bmp4, t (7) = 0. (Fig. 10d) . In line with the data derived from P14 Cnp-Cre:Sox2 fl/fl hybrids, the number of APC + TCF7l2 + newly formed premyelinating OLs (Fig. 10e, arrowheads) (Fig. 10f) , indicating that Sox2 ablation perturbs the rate of oligodendrocyte generation.
Discussion
The current study resolved a key question regarding the role of Sox2 in the oligodendroglial lineage progression in the postnatal murine spinal cord. Two previous studies reported discrepant observations. Using the Sox10-Cre:Sox2 fl/fl model to constitutively delete Sox2 in OPCs, Hoffmann and colleagues demonstrated that Sox2 is required for spinal cord myelination [9] . Axonal myelination occurs predominantly during postnatal development in the CNS of both human and rodents. Unfortunately, this study did not analyze spinal myelination beyond the neonatal ages. A subsequent study reported that Sox2 seems dispensable for myelination in the postnatal spinal cord [10] . However, this study used a non-cell-specific Sox2 deletion paradigm. In the current study, we analyzed myelination in the postnatal spinal cord of the cellspecific Sox2 mutants (Sox10-Cre:Sox2 fl/fl ) and conclude that Sox2 is indispensable for spinal cord myelination. The experimental data from the current and our previous studies [11] suggest that Sox2 is an intrinsic positive regulator for CNS myelination, weakening a CNS regionspecific (brain vs spinal cord) role of Sox2 in developmental myelination.
In the CNS, Sox2 is highly expressed in NSCs and downregulated or absent upon differentiation into neural progenitors [2] . Recent studies have reached the consensus that OPCs express Sox2 in the embryonic and early postnatal CNS in vivo [9, 10, 22] . However, whether OPCs express Sox2 in the adult CNS is still controversial [10, 23] . By leveraging Cre-LoxP-based genetic labeling (Sox2-CreER
T2
:Rosa-loxP-STOP-loxP-EYFP), we demonstrate that adult OPCs from different CNS regions exhibit endogenous Sox2 promoter activity and express Sox2 albeit at a lower level, thus arguing against a CNS region-dependent Sox2 expression in adult OPCs. This notion is consistent with recent single-cell RNAseq data demonstrating that adult OPCs in different CNS regions are homogenous at the transcription level [21] . At the functional level, our previous and current data have unequivocally demonstrated that Sox2 is essential for OPC proliferation in the postnatal brain and spinal cord. It is wellestablished that OPCs are uniformly distributed throughout CNS regions and represent the largest population of proliferating cells in the adult CNS [24] , and adult OPCs are responsible for oligodendrogenesis albeit at a slower rate, myelin turnover, and/or adaptive myelination [25] [26] [27] . It is plausible to speculate that Sox2 regulates the homeostasis of adult OPCs, adult oligodendrogenesis, and/or adaptive myelination. Future studies are needed to prove or falsify this prediction.
Our recent data [11] report that oligodendrocyte number and myelin gene expression are unchanged at P14 in the spinal cord of Cnp-Cre:Sox2 fl/fl mutants compared to non-Cre controls. Based on these observations, one can argue that Sox2 is dispensable for OL differentiation in the postnatal spinal cord, as concluded by previous study [10] . Alternatively, it is possible that Sox2 may regulate the timing of OL differentiation in the postnatal spinal cord. If this possibility happens, oligodendrocyte population should be reduced at some time points before P14. To this end, we analyzed oligodendrocyte differentiation and myelin gene expression at P8, the approximate peak of OL differentiation in the murine spinal cord, and found that OL differentiation and myelination are significantly decreased in the P8 spinal cord of Cnp-Cre:Sox2 fl/fl mutants. The time course analysis of Cnp-Cre:Sox2 fl/fl hybrids favors the latter possibility that Sox2 is an intrinsic positive timer regulating the timing of oligodendrocyte differentiation in the postnatal spinal cord. Another novel finding in the current study is that Sox2 regulates OPC proliferation in a developmental stage-dependent (embryonic vs spinal cord) manner.
Using Sox10-Cre:Sox2 fl/fl embryos, we confirmed that Sox2 does not regulate OPC proliferation in the embryonic spinal cord, a conclusion that is in line with the one by Hoffmann et al. [9] . Interestingly, our data show that Sox2 plays a crucial role in postnatal OPC proliferation in the spinal cord.
How Sox2 promotes oligodendrocyte differentiation and myelination is an open question. Sox2 is a transcription factor that either activates or silences its target genes depending on recruiting its partners of co-activators or co-repressors, respectively in different contexts [28] [29] [30] [31] . Previous study suggests that Sox2 represses miR145, thus preventing miR145 from inhibiting several pro-differentiation factors [9] . Our preliminary study of co-immunoprecipitation in combination with mass spectrometry (CoIP-MS) showed that, in the Oli-neu oligodendrocyte cell line [32] , Sox2 interacted with transcriptional repressors HDAC1/2 and YY1 and transcriptional activators TCF7l2, and Olig1/2 (data not shown), all of which have been shown to promote oligodendrocyte differentiation and myelination [13, 15, 22, [33] [34] [35] . Recent ChIPSeq data show that Sox2 may target the signaling pathways of Wnt, Akt, and Notch in the adult cerebral cortex [36] , all of which have been shown to regulate OL differentiation and myelination [37] . Since Sox2-expressing cells in the adult cerebral cortex are astrocytes [36] and OPCs (Fig.  1d) , it is not quite clear whether Sox2 targets these pathways in astrocytes or in OPCs. Further experimental data are needed to link Sox2 with those pathways, if any, in the context of oligodendroglial lineage cells, and importantly, how Sox2 modulates those pathways also warrants more investigations.
In summary, our data from genetic approaches unequivocally prove that the pluripotency factor Sox2 plays a crucial role in coordinating OPC proliferation and OL differentiation and is required for developmental myelination in the postnatal murine spinal cord. Our study provides justification that Sox2 may be a therapeutic target for overcoming OPC differentiation arrest in CNS dysmyelinating and demyelinating disorders.
Materials and Methods
Animals
Animals and procedures used in the study were covered and approved by the Institutional Animal Care and Use Committee (IACUC) of UC Davis. Animals were housed at 12 h light/dark cycle with access to food and drink, and both male and female mice were used in this study. All transgenic mice were crossed and maintained on a C57BL/6J back- fl/fl whereas non-Cre controls were referred as to Sox2 fl/+ or Sox2 fl/fl that do not carry Cre transgene. For studies using timed pregnant mice (Fig. 2) , we placed male and female mice into one cage around 5:00 pm in the late afternoon, and the female mice were designated as pregnancy if the sperm plugs were seen by 10:00 am of the next day, and the embryos were assigned as embryonic day 0.5 (E0.5). For postnatal studies, the day when pups were born was designated as postnatal day 0 (P0).
Tamoxifen, BrdU, and Edu Treatment
Tamoxifen (TM) (T5648; Sigma-Aldrich) was dissolved in mixture of ethanol and sunflower oil (1:9 by volume) at a concentration of 30 mg/ml [13, 14] . Tamoxifen was administrated intraperitoneally to adult Sox2-CreER T2 :Rosa-EYFP mice (Fig. 1) at a dose of 1 mg (~35 μl) daily for five consecutive days, subcutaneously to neonatal pups (Pdgfrα-CreER T2 :Sox2 fl/fl and non-Cre controls) on P1, P2, and P3 daily at a dose of 10 μl (300 μg) once a day (Fig. 6 and Fig. 7) , and intraperitoneally to Plp-CreER T2 :Sox2 fl/fl and non-Cre controls daily on P10, P11, and P13 at a dose of 20 μl (600 μg) (Fig. 9 ). Animals were sacrificed at time points indicated in each figure. BrdU or EdU (10 mg/ml, dissolved in saline) was intraperitoneally injected to Sox2 cKO and control littermates at a dose of 100 μg/g body weight 2 h prior to sacrifice.
Tissue Harvesting and Processing for Histology
After anesthetized by ketamine/xylazine mixture, mice were transcardially perfused with ice-cold PBS. Spinal cord was dissected out and immediately placed on dry ice (for protein or RNA extraction) or post-fixed in 4% paraformaldehyde (PFA) (for histological study). After post-fix in 4% PFA for 2 h at room temperature, the spinal cord was washed with PBS, three times, 15 min each time. Tissue samples were then cryoprotected in 30% sucrose (dissolved in PBS) for 20 h and cut into 16-μm-thick sections on Leica Cryostats. Sections were stored under − 80°C until use for immunohistochemistry or mRNA in situ hybridization.
Jackson ImmunoResearch. Brdu and Edu (Click-iT EdU imaging kits, Invitrogen C10339) immunostaining were performed as in previous study [13, 14] .
Protein Extraction and Western Blot
The frozen mouse spinal cord was homogenized in RIPA buffer (Cell Signaling Technology, #9806) supplemented with the protease/phosphatase inhibitor cocktail buffer (Cell Signaling Technology, #5872) and PMSF (Cell Signaling Technology, #8553) at a ratio of 100 mg of tissue to 1 ml of buffer. Lysates were sonicated, incubated on ice for 30 min, and centrifuged at 14,000g for 10 min. The supernatants were assessed for protein concentration using the BCA protein assay kit (Thermo Scientific, #23235). Western blot was performed according to the protocols in our previous studies [13, 14] . A total of 30 μg protein extracts was separated by anykD precast polyacrylamide gel (Bio Rad, #4569033) and transferred to nitrocellulose immobilization membranes (Bio Rad, #1704158) using Trans-Blot Turbo transfer system (Bio Rad, #1704150). Membranes were blocked for 1 h in 5% BSA (Cell Signaling Technology, #9998) at room temperature and incubated with the primary antibody overnight at 4°C. Subsequently, membranes were washed three times 10 min each in TBST buffer (Tris 25 mM, KCI 3 mM, NaCl 140 mM, pH 7.4, and Tween 0.1%) and incubated with secondary antibodies for 1 h at room temperature. Membranes were washed three times in the same wash buffer, and detection was performed by exposing the membranes to Pewmium X-ray Film (PHENIX, #F-BX57).
The following antibodies were used for Western blot: MBP (NB600-717, RRID: AB_2139899, 1:1000; Novus), Cnp (C5922, RRID: AB_823640, 1:1000; Sigma), and beta-actin (3700, RRID: AB_2242334, 1:1000; Cell Signaling Technology).
RNA Extraction, cDNA Preparation, and Real-Time Quantitative PCR (RT-qPCR)
Total spinal cord RNA was extracted by using the commercial isolation kit (Qiagen catalog#: 74804) with additional oncolumn DNase I digestion to eliminate genomic DNA contamination. RNA quality was assessed by Agilent Bioanalyzer 2100. Only RNAs with RNA Integrity Number (RIN) greater than 6.8 were used for subsequent complementary DNA (cDNA) preparation. cDNA was prepared by Qiagen Omniscript RT Kit (catalog#: 205111) with 2 μg RNA in 20 μl reaction buffer. The resulting 20 μl cDNA was further diluted with TE buffer (pH 8.0) to a total volume of 400 μl (380 μl TE buffer to 20 μl cDNA stock solution), and 1 μl of the diluted cDNA solution (equivalent to 5 ng RNA) was used as templates for RT-qPCR. We used Sybr green-based method (QIAGEN catalog#: 204143) for qPCR. In our study, the Ct 
Confocal Image Acquisition and Quantification
Nikon laser-scanning confocal microscope was used to acquire confocal images. Laser settings remained consistent across different mouse genotypes of histological sections. Nikon EZ-C1 FreeViewer v3.90 was used for cell quantification and area calculation. To quantify cell density, four projected confocal images at 20× (oil lens) magnification (10 μm optical thickness from 11 consecutive stacked 1-μm confocal optical slices,~330,000 μm 2 per 20× image) were obtained from same locations in the spinal cord of Sox2 cKO and non-Cre control mice. To increase the accuracy of OPC and OL quantification, we included the nuclear Sox10 (or Olig2) immunostaining with the OPC marker PDGFRα (or NG2) and the differentiated OL marker CC1. Only PDGFRα + or CC1 + cells with nuclear Sox10 (or Olig2) signals were counted as individual OPCs or OLs. Similarly, to increase the accuracy of premyelinating OL quantification, we used double immunohistochemistry of the cell surface antigen APC and the nuclear antigen TCF7l2. Only APC + cells with nuclear TCF7l2 signals were counted as individual premyelinating OLs. The NIH ImageJ software was used to quantify the relative intensity of MBP and SMI312 immunoreactivity.
Accelerating Rotarod Test
Motor performance and coordination were measured by accelerating rotarod test machine (Columbus instruments, Rotamex-5 Rota rod). The following parameter settings were used: starting speed 4 rotations per minute (rpm), speed increased by 1.2 rpm every 10 s, maximal speed 40 rpm. The retention time was recorded for each mouse which is defined as the time duration that a mouse is retained on the rorating rods prior to falling off.
Semi-Thin Section Preparation and Toluidine Blue Staining of Myelin
Mice were anesthetized by ketamine/xylazine mixture, then perfused with 60 ml 4% paraformaldehyde (dilute with phosphate buffer, EMS, 11601-40, pH 7.4) and 60 ml 3% glutaraldehyde (Electron Microscopy Science, 16130, dilute in PBS, pH 7.4) at a speed of 5 ml per minute. Spinal cord was carefully dissected out and fixed with 3% glutaraldehyde overnight followed by wash with sodium cacodylate (Electron Microscopy Science, EMS, 11653) twice, 10 min each time, and then post-fixed with 2% (w/v) osmium tetroxide (Electron Microscopy Science, 19152) for 1.5 h and wash with sodium cacodylate twice, 10 min each time. The resulting spinal cord was dehydrated with gradient ethanol of 50, 70, 90, and 100% followed by wash with propylene oxide for three times, 30 min each time, and incubation with 1:1 mixture of propylene oxide:Eponate resin overnight, and with 3:1 mixture of propylene oxide:Eponate resin for 10 h, and incubation with 100% Eponate resin overnight. Transverse sections were embedded in EMBED812-Resin for 2 days at 65°. Semi-thin (500 nm) were cut by using a Leica EM UC7 microtome. Semi-thin sections were dry and incubated with 2% toluidine blue (Cat#19451, Ted Pella Inc.) at 100°C for 2 min, followed by imaging on Olympus BX61 microscope.
Statistical Analyses
Quantification was performed by blinded observers. At least three sections from each mouse were used, and 3-7 mice were quantified. Data were presented as mean ± s.d. except stated otherwise. We used graphs of scatter plots to present the quantification data throughout our manuscript, and each circle, square, or triangle represents one mouse. Shapiro-Wilk approach was used for testing data normality. The statistical methods were described in the figure legends. For two-tailed Student's t test, P value was presented in each graph, and t value and degree of freedom (df) were presented as t (df) in figure legends. Welch's correction was used in Student's t test if the variance of two groups of datasets was not equal. For comparisons among three or more groups, one-way ANOVA followed by Tukey's post-hoc test was used. We used GraphPad Prism version 5.0 to perform all statistical analyses and data plotting. P value less than 0.05 was considered as significant. ns stands for not significant with P value greater than 0.05.
